Neovascularization in an arterio-venous loop-containing tissue engineering chamber: Role of NADPH oxidase

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 5B, 2008, Pages 2062-2072

  Jiang, F ^a,c   Zhang, G ^a   Hashimoto, I ^b   Kumar, B S ^a   Bortolotto, S ^a   Morrison, W A ^a   Dusting, G J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c Bernard O'Brien Institute of Microsurgery   (Australia)

Author keywords

Angiogenesis; NADPH oxidase; Redox signalling; Tissue engineering

Indexed keywords

CARBONIC ACID DERIVATIVE; MESSENGER RNA; POLYMER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD VESSEL; CHEMISTRY; CYTOLOGY; ENDOTHELIUM CELL; EQUIPMENT DESIGN; FEMORAL ARTERY; FEMORAL VEIN; GENETICS; IMMUNOHISTOCHEMISTRY; INSTRUMENTATION; MALE; METABOLISM; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); OXIDATION REDUCTION REACTION; PATHOLOGY; PRACTICE GUIDELINE; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIOVENOUS ANASTOMOSIS; BLOOD VESSELS; CARBONATES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EQUIPMENT DESIGN; FEMORAL ARTERY; FEMORAL VEIN; GUIDELINES AS TOPIC; IMMUNOHISTOCHEMISTRY; MALE; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; OXIDATION-REDUCTION; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPEROXIDES; TISSUE ENGINEERING;

EID: 55249111100     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00199.x     Document Type: Article

References (38)

1. Cassell OC. Hofer SO, Morrison WA, Knight KR. Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plast Surg. 2002 55 : 603 10.
2. Cassell OC, Morrison WA, Messina A, Penington AJ, Thompson EW, Stevens GW, Perera JM, Kleinman HK, Hurley JV, Romeo R, Knight KR. The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue. Ann N YAcad Sci. 2001 944 : 429 42.
3. Hofer SO, Knight KM, Cooper-White JJ, O'Connor AJ, Perera JM, Romeo-Meeuw R, Penington AJ, Knight KR, Morrison WA, Messina A. Increasing the volume of vascularized tissue formation in engineered constructs: an experimental study in rats. Plast Reconstr Surg. 2003 111 : 1186 92 discussion 93-4.
4. Messina A, Bortolotto SK, Cassell OC, Kelly J, Abberton KM, Morrison WA. Generation of a vascularized organoid using skeletal muscle as the inductive source. FASEB J. 2005 19 : 1570 2.
5. Mian R, Morrison WA, Hurley JV, Penington AJ, Romeo R, Tanaka Y, Knight KR. Formation of new tissue from an arte-riovenous loop in the absence of added extracellular matrix. Tissue Eng. 2000 6 : 595 603.
6. Knight KR, Uda Y, Findlay MW, Brown DL, Cronin KJ, Jamieson E, Tai T, Keramidaris E, Penington AJ, Rophael J, Harrison LC, Morrison WA. Vascularized tissue-engineered chambers promote survival and function of transplanted islets and improve glycemic control. Faseb J. 2006 20 : 565 7.
7. Morritt AN, Bortolotto SK, Dilley RJ, Han X, Kompa AR, McCombe D, Wright CE, Itescu S, Angus JA, Morrison WA. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation. 2007 115 : 353 60.
8. Lokmic Z. Stillaert F. Morrison WA. Thompson EW, Mitchell GM. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J. 2007 21 : 511 22.
9. Hofer SO, Mitchell GM, Penington AJ, Morrison WA, RomeoMeeuw R. Keramidaris E. Palmer J, Knight KR. The use of pimonidazole to characterise hypoxia in the internal environment of an in vivo tissue engineering chamber. Br J Plast Surg. 2005 58 : 1104 14.
10. Simons M. Integrative signaling in angiogenesis. Mol Cell Biochem. 2004 264 : 99 102.
11. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW. Novel role of gp91(phox)-containing I/IAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res. 2002 91 : 1160 7.
12. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of I/IAD(P)H oxidase. Mol Cell Biochem. 2004 264 : 85 97.
13. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999 85 : 753 66.
14. Griendling KK, Sorescu D, Ushio-Fukai M. I/IAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000 86 : 494 501.
15. Jiang F, Drummond GR, Dusting GJ. Suppression of oxidative stress in the endothelium and vascular wall. Endothelium. 2004 11 : 79 88.
16. Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, Alexander RW. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation. 2005 111 : 2347 55.
17. Jiang F, Guo Y, Salvemini D, Dusting GJ. Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. Br J Pharmacol. 2003 139 : 1127 34.
18. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular 0(2)(-) and systolic blood pressure in mice. Circ Res. 2001 89 : 408 14.
19. Angermayr B, Fernandez M, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats. Gut. 2006 56 : 560 4.
20. Roy S, Khanna S, Nallu K, Hunt TK, Sen CK. Dermal wound healing is subject to redox control. Mol Ther 2006 13 : 211 20.
21. Vallet P, Charnay Y, Steger K, Ogier-Denis E, Kovari E, Herrmann F, Michel JP, Szanto I. Neuronal expression of the NADPH oxidase N0×4, and its regulation in mouse experimental brain ischemia. Neuroscience. 2005 132 : 233 8.
22. Datla SR, Peshavariya H, Dusting GJ, Mahadev K, Goldstein BJ, Jiang F. Important role of NOX4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler Thromb Vase Biol. 2007 27 : 2319 24.
23. Ago T, Kitazono T, Ooboshi H, lyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, lida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation. 2004 109 : 227 33.
24. Chamseddine AH, Miller FJ, Jr. Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells. Am J Physiol Heart Circ Physiol. 2003 285 : H2284 9.
25. Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, Karwande SV, Stringham JC, Bull DA, Gleich M, Kennedy TP, Hoidal JR. Transforming growth factor-betal1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006 290 : L661 73.
26. Su B, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, Goldschmidt-Clermont PJ, Flavahan NA. Redox regulation of vascular smooth muscle cell differentiation. Circ Res. 2001 89 : 39 46.
27. Shen WL, Gao PJ, Che ZQ, Ji KD, Yin M, Yan C, Berk BC, Zhu DL. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-ll induced adventitial fibroblast phenotypic differentiation. Biochem Biophys Res Commun. 2006 339 : 337 43.
28. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal. 2006 18 : 69 82.
29. Kikuchi H, Fujinawa T, Kuribayashi F, Nakanishi A, Imajoh-Ohmi S, Goto M, Kanegasaki S. Induction of essential components of the superoxide generating system in human monoblastic leukemia U937 cells. J Biochem. 1994 116 : 742 6.
30. Abid MR, Kachra Z, Spokes KC, Aird WC. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett. 2000 486 : 252 6.
31. Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA, Caldwell RW, Caldwell RB. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol. 2005 167 : 599 607.
32. Jain RK. Molecular regulation of vessel maturation. NatMed. 2003 9 : 685 93.
33. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994 55 : 410 22.
34. Ninomiya K, Takahashi A, Fujioka Y, Ishikawa Y, Yokoyama M. Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells. Hypertens Res. 2006 29 : 269 76.
35. Sharifi BG, Zeng Z, Wang L, Song L, Chen H, Qin M, Sierra-Honigmann MR, Wachsmann-Hogiu S, Shah PK. Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vase Biol. 2006 26 : 1273 80.
36. Reuter U, Champion C, Kain HL. Transdifferentiation of human monocytes into fibroblast-like cells in vitro. Ger J Ophthalmol. 1995 4 : 182 7.
37. Loomans CJ, Wan H, de Crom R, van Haperen R, de Boer HC, Leenen PJ, Drexhage HA, Rabelink TJ, van Zonneveld AJ, Staal FJ. Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression. Arterioscler Thromb Vase Biol. 2006 26 : 1760 7.
38. Jabs A, Moncada GA, Nichols CE, Waller EK, Wilcox JN. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue. J Vase Res. 2005 42 : 174 80.